Chromosomal Aberrations in Pediatric Patients with Moderate/Severe Developmental Delay/Intellectual Disability with Abundant Phenotypic Heterogeneities: A Single-center Study
WU Dan,WU Yi,LAN Yulong,LAN Shaocong,Zhiwei Zhong,LI Duo,Zexin Zheng,WANG Hongwu,MA Lian,Dan WU,Yi WU,Yulong LAN,Shaocong LAN,Duo LI,Hongwu WANG,Lian MA
DOI: https://doi.org/10.1016/j.pediatrneurol.2023.06.001
IF: 4.21
2023-06-23
Pediatric Neurology
Abstract:Introduction This study aimed to examine the clinical usefulness of chromosome microarray (CMA) for selective implementation in patients with unexplained moderate or severe developmental delay/intellectual disability (DD/ID) and/or combined with different dysphonic features in the Han Chinese population. Methods We retrospectively analyzed data on 122 pediatric patients with unexplained isolated moderate/severe DD/ID with or without autism spectrum disorders (ASD), epilepsy, dystonia, and congenital abnormalities from a single-center neurorehabilitation clinic in southern China. Results A total of 46 probands (37.7%) had abnormal CMA results among the 122 study patients. With the exclusion of aneuploidies, uniparental disomies and multiple homozygotes, 37 patients harbored 39 pathogenic copy number variations (pCNVs) (median [IQR] size: 3.57 [1.6-7.1] Mb; 33 deletions and 6 duplications), enriched in chromosomes 5, 7, 15, 17, 22, with a markedly high prevalence of Angelman/Prader Willi syndrome (24.3% [9/37]). Three rare deletions in the regions of 5q33.2q34, 17p13.2, and 13q33.2 were reported, with specific delineation of clinical phenotypes. The frequencies of pCNVs were 18%, 33.3%, 38.89%, 41.67%, and 100% for patients with 1, 2, 3, 4, and 5 study phenotypes, respectively; patients with more concomitant abnormalities in the heart, brain, craniofacial region and/or other organs had a higher CMA diagnosis yield and pCNV prevalence ( P <0.05). Conclusions Clinical application of CMA as a first-tier test among patients with moderate/severe DD/ID combined with congenital structural anomalies improved diagnostic yields and the quality of clinical management in this series of patients.
pediatrics,clinical neurology